
Sarda Proteins Files 35th Annual Report for FY26
Sarda Proteins Ltd has filed its 35th Annual Report for FY 2025-26. The report highlights a significant capital event where over ₹83 crore in fresh equity was introduced through warrant conversions by the Promoter Group, transferring control to Onix Renewable Limited. This led to a substantial increase in net worth from ₹2.38 crore to ₹86.21 crore. Operationally, revenue from the legacy trading business declined by 33.3% to ₹16.14 crore. However, profitability saw an improvement from a low base, with profit before tax rising to ₹63.51 lakh and profit after tax to ₹45.44 lakh, partly supported by other income. The company has also expanded its business objects to include agriculture, horticulture, and food processing, and has approved a rights issue of up to ₹90 crore, with a significant portion earmarked for acquiring stakes in Fresita Food Private Limited and Urja Protein India Private Limited, signaling a strategic shift towards becoming an agri-food group.
Key Highlights
- FY26 saw ₹83+ crore equity infusion, boosting net worth to ₹86.21 crore.
- Revenue from operations fell 33.3% to ₹16.14 crore.
- Profitability improved significantly from a low base.
- Control transferred to Onix Renewable Limited.
- Strategic shift towards agri-food business with planned acquisitions.
Price Impact
More from SRDAPRT